Xiaoyi Duan

277 West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Retraction Note: Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.

Retraction Note: Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.

Journal: Clinical and experimental medicine

Published: June 19, 2026

Early Changes in the Neutrophil-to-Lymphocyte Ratio are Associated with Conversion Outcomes in Advanced Hepatocellular Carcinoma Treated with HAIC-Based Triple Therapy.

Early Changes in the Neutrophil-to-Lymphocyte Ratio are Associated with Conversion Outcomes in Advanced Hepatocellular Carcinoma Treated with HAIC-Based Triple Therapy.

Journal: Journal of hepatocellular carcinoma

Published: May 18, 2026

Habitat-aware radiomics and adaptive 2.5D deep learning predict treatment response and long-term survival in ESCC patients undergoing neoadjuvant chemoimmunotherapy.

Habitat-aware radiomics and adaptive 2.5D deep learning predict treatment response and long-term survival in ESCC patients undergoing neoadjuvant chemoimmunotherapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 04, 2025

Integrated motion-corrected extracellular volume fraction mapping reveals subtle extracellular remodeling in remote myocardium following chronic myocardial infarction.

Integrated motion-corrected extracellular volume fraction mapping reveals subtle extracellular remodeling in remote myocardium following chronic myocardial infarction.

Journal: BMC medical imaging

Published: May 10, 2025

Editorial Expression of Concern: Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.

Editorial Expression of Concern: Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.

Journal: Clinical and experimental medicine

Published: April 21, 2025

18F-PSMA-1007 PET/CT tumor volume quantification: a game-changing prognostic biomarker for first-line ARPI therapy in metastatic castration-resistant prostate cancer.

18F-PSMA-1007 PET/CT tumor volume quantification: a game-changing prognostic biomarker for first-line ARPI therapy in metastatic castration-resistant prostate cancer.

Journal: Japanese journal of radiology

Published: April 03, 2025

Magnetic resonance imaging of focal organizing pneumonia: differential diagnosis with peripheral lung carcinoma.

Magnetic resonance imaging of focal organizing pneumonia: differential diagnosis with peripheral lung carcinoma.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: January 27, 2025

Pre-Treatment 18F-FDG PET/CT reveals altered brain metabolic network connectivity in patients with diffuse large B-cell lymphoma: Implications for cancer-related cognitive impairment.

Pre-Treatment 18F-FDG PET/CT reveals altered brain metabolic network connectivity in patients with diffuse large B-cell lymphoma: Implications for cancer-related cognitive impairment.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: December 11, 2024

The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone.

The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone.

Journal: British journal of cancer

Published: October 20, 2024

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study.

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study.

Journal: BMC cancer

Published: October 09, 2024

Using 18F-FDG PET/CT to predict programmed cell death ligand expression in non-small cell lung cancer via metabolic tumour heterogeneity.

Using 18F-FDG PET/CT to predict programmed cell death ligand expression in non-small cell lung cancer via metabolic tumour heterogeneity.

Journal: The British journal of radiology

Published: August 16, 2024

Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer.

Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer.

Journal: Computers in biology and medicine

Published: April 26, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026